Anaphylaxis and Mast Cell Disease: What Is the Risk?

被引:45
作者
Akin, Cem [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02445 USA
关键词
Anaphylaxis; Mastocytosis; Mast cells; C-kit; HYMENOPTERA VENOM ALLERGY; SYSTEMIC MASTOCYTOSIS; C-KIT; IDIOPATHIC ANAPHYLAXIS; BONE-MARROW; ACTIVATING MUTATION; SERUM TRYPTASE; DISORDERS; CLASSIFICATION; IMMUNOTHERAPY;
D O I
10.1007/s11882-009-0080-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Mastocytosis is a proliferative disorder of the hematopoietic mast cell progenitor that results from expansion of a clone carrying the D816V c-kit mutation. Based on the dramatic increase in incidence of anaphylaxis in patients with mastocytosis, recent studies analyzed the presence of clonal mast cell markers, including D816V c-kit mutation, in patients with recurrent IgE- and non-IgE-mediated anaphylaxis. These studies demonstrated the presence of an aberrant mast cell clone in a significant proportion of patients with unexplained anaphylaxis, or anaphylaxis due to hymenoptera venom. Clonal mast cell disease should be suspected in particular in patients presenting with profound cardiovascular manifestations such as hypotension and syncope in the absence of urticaria.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [41] Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?
    Valent, Peter
    Akin, Cem
    Hartmann, Karin
    Reiter, Andreas
    Gotlib, Jason
    Sotlar, Karl
    Sperr, Wolfgang R.
    Degenfeld-Schonburg, Lina
    Smiljkovic, Dubravka
    Triggiani, Massimo
    Horny, Hans-Peter
    Arock, Michel
    Galli, Stephen J.
    Metcalfe, Dean D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) : 1866 - 1874
  • [42] Spectrum of mast cell activation disorders
    Petra, Anastasia I.
    Panagiotidou, Smaro
    Stewart, Julia M.
    Conti, Pio
    Theoharides, Theoharis C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (06) : 729 - 739
  • [43] Mast Cell Activation Syndrome: A Review
    Frieri, Marianne
    Patel, Reenal
    Celestin, Jocelyn
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (01) : 27 - 32
  • [44] Molecular basis of mast cell disease
    Soucie, Erinn
    Brenet, Fabienne
    Dubreuil, Patrice
    MOLECULAR IMMUNOLOGY, 2015, 63 (01) : 55 - 60
  • [45] Drug allergy in mast cell disease
    Brockow, Knut
    Bonadonna, Patrizia
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 12 (04) : 354 - 360
  • [46] Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation
    Toro, Tania Zuluaga
    Hsieh, Fred H.
    Bodo, Juraj
    Dong, Henry Y.
    Hsi, Eric D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (01) : 31 - 40
  • [47] Pediatric Mast Cell Disease: What's the Big (Hematologic) Deal?
    Parker, Robert I.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (04) : 527 - 528
  • [48] Immunology and Clinical Manifestations of Non-Clonal Mast Cell Activation Syndrome
    Cardet, Juan-Carlos
    Castells, Mariana C.
    Hamilton, Matthew J.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (01) : 10 - 18
  • [49] Anaphylaxis to drugs: Overcoming mast cell unresponsiveness by fake antigens
    Pichler, Werner J.
    ALLERGY, 2021, 76 (05) : 1340 - 1349
  • [50] AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management
    Weiler, Catherine R.
    Austen, K. Frank
    Akin, Cem
    Barkoff, Marla S.
    Bernstein, Jonathan A.
    Bonadonna, Patrizia
    Butterfield, Joseph H.
    Carter, Melody
    Fox, Charity C.
    Maitland, Anne
    Pongdee, Thanai
    Mustafa, S. Shahzad
    Ravi, Anupama
    Tobin, Mary C.
    Vliagoftis, Harissios
    Schwartz, Lawrence B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (04) : 883 - 896